Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube
- PMID: 24100801
- DOI: 10.1007/s00404-013-3041-3
Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube
Abstract
Background: Among all gynecological malignancies, ovarian cancer is associated with the highest rate of mortality. Recent findings now propose a pivotal role for the fallopian tube during ovarian cancer pathogenesis.
New insights: Until recently, ovarian cancer was thought to derive from the ovarian surface epithelium. Nevertheless, attempts to define a precursor lesion from this tissue failed. Instead, prophylactic surgery performed on BRCA mutation carriers and subsequent histological analyses revealed a characteristic pre-neoplastic alteration at the fimbriated end of the fallopian tubes, the so-called serous tubal intraepithelial carcinoma (STIC). By morphology and molecular genetics, STIC was found to resemble serous ovarian cancer. As STIC can also be detected in >60 % of BRCA-unrelated serous ovarian carcinomas, it is now considered to be the precursor of the most common ovarian cancer subtype.
Consequences: Based on this hypothesis, a salpingectomy, i.e., the removal of the post-reproductive fallopian tubes may remove the actual site of tumorigenesis and thereby prevent spreading over the ovarian surface and throughout the peritoneum. Consequently, prophylactic salpingectomy might protect against serous ovarian cancer. Moreover, the procedure interrupts the connection between the uterine cavity and the lesser pelvis. Hence, it prevents the ascension of exfoliated endometrial cells which will likely reduce the incidence of endometrioid and clear cell ovarian cancers. Increasing evidence suggests that serous ovarian cancer originates from the fimbriated distal end of the fallopian tube, whereas the ovary gets only involved at a later stage.
Conclusion: Given the lack of suitable screening or early detection strategies for ovarian cancer, post-reproductive salpingectomy deserves serious consideration as a prophylactic intervention that will likely confer significant protection against an often deadly disease.
Similar articles
-
The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.J Obstet Gynaecol Can. 2014 Feb;36(2):133-140. doi: 10.1016/S1701-2163(15)30659-9. J Obstet Gynaecol Can. 2014. PMID: 24518912 Review.
-
[Fallopian tube: the dark face of pelvic carcinogenesis].Ann Pathol. 2011 Oct;31(5):345-52. doi: 10.1016/j.annpat.2011.06.008. Epub 2011 Sep 25. Ann Pathol. 2011. PMID: 21982240 Review. French.
-
Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.Surg Oncol. 2015 Dec;24(4):335-44. doi: 10.1016/j.suronc.2015.09.008. Epub 2015 Oct 8. Surg Oncol. 2015. PMID: 26690823 Review.
-
Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?Int J Gynecol Pathol. 2013 Jul;32(4):353-7. doi: 10.1097/PGP.0b013e318264ae09. Int J Gynecol Pathol. 2013. PMID: 23722507
-
Are all pelvic (nonuterine) serous carcinomas of tubal origin?Am J Surg Pathol. 2010 Oct;34(10):1407-16. doi: 10.1097/PAS.0b013e3181ef7b16. Am J Surg Pathol. 2010. PMID: 20861711
Cited by
-
Primary fallopian tube carcinoma: review of MR imaging findings.Insights Imaging. 2015 Aug;6(4):431-9. doi: 10.1007/s13244-015-0416-y. Epub 2015 Jul 7. Insights Imaging. 2015. PMID: 26150249 Free PMC article.
-
Magnetic resonance diffusion-weighted imaging in diagnostics of primary fallopian tube carcinoma - is it useful?Pol J Radiol. 2018 Apr 20;83:e161-e165. doi: 10.5114/pjr.2018.75642. eCollection 2018. Pol J Radiol. 2018. PMID: 30038695 Free PMC article.
-
Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer.Biomark Cancer. 2015 Aug 16;7:31-8. doi: 10.4137/BIC.S28378. eCollection 2015. Biomark Cancer. 2015. PMID: 26327782 Free PMC article.
-
Iron addiction: a novel therapeutic target in ovarian cancer.Oncogene. 2017 Jul 20;36(29):4089-4099. doi: 10.1038/onc.2017.11. Epub 2017 Mar 20. Oncogene. 2017. PMID: 28319068 Free PMC article.
-
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.BMC Cancer. 2015 Aug 19;15:593. doi: 10.1186/s12885-015-1597-y. BMC Cancer. 2015. PMID: 26286255 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials